Apr 20, 2021 10:29 AM (GMT+8) · EqualOcean
Recently, "Tianhong Shengjie" obtained nearly 100 million yuan of round B financing. Previously, the company completed tens of millions of yuan a + round financing, jointly invested by Su Gaoxin venture capital and green river investment. Founded in 2016, Tianhong Shengjie, as the first comprehensive product platform in the field of intravenous therapy in China, focuses on the diseases that are urgently needed in clinic, such as venous obstructive diseases, VTE, reflux diseases, etc., and provides product solutions.

This text is a result of machine translation.